Guggenheim Capital’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,947
Closed -$312K 2240
2021
Q2
$312K Sell
5,947
-613
-9% -$34.9K ﹤0.01% 2001
2021
Q1
$364K Buy
+6,560
New +$297K ﹤0.01% 1877
2013
Q4
Sell
-1,704
Closed -$9K 3262
2013
Q3
$9K Buy
1,704
+826
+94% +$5.9K ﹤0.01% 3047
2013
Q2
$7K Buy
+878
New +$10.6K ﹤0.01% 3024

Other funds holding VCEL

Guggenheim Capital's VCEL Position: Q3 2021 in Review

Guggenheim Capital sold out of Vericel Corp (VCEL) in Q3 2021, closing a stake of 5,947 shares — an estimated $312K sold.

Guggenheim Capital first reported a position in VCEL in Q2 2013 and held it in 4 quarters. The position peaked at $364K in Q1 2021. 202 funds tracked by Wall St. Rank hold VCEL as of Q3 2021.

  • Guggenheim Capital reported no remaining Vericel Corp position as of Q3 2021 after selling out during the quarter.
  • Guggenheim Capital sold 5,947 Vericel Corp shares in Q3 2021, an estimated $312K.
  • Guggenheim Capital first reported a position in Vericel Corp in Q2 2013 and held it in 4 quarters.
  • Guggenheim Capital's Vericel Corp position peaked at $364K in Q1 2021.
  • 202 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2021.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.